| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(05)63326-0 |
| P698 | PubMed publication ID | 9288051 |
| P2093 | author name string | M Ernst | |
| R M Cohen | |||
| A J Zametkin | |||
| J A Matochik | |||
| D Pascualvaca | |||
| P2860 | cites work | 'Theory of mind' in the brain. Evidence from a PET scan study of Asperger syndrome | Q34418139 |
| Regional and cellular fractionation of working memory | Q35997453 | ||
| Neurofunctional mechanisms in autism | Q41076363 | ||
| Presynaptic dopaminergic deficits in Lesch-Nyhan disease | Q42517524 | ||
| P433 | issue | 9078 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autism | Q38404 |
| autistic child | Q110955678 | ||
| dopamine | Q170304 | ||
| P304 | page(s) | 638 | |
| P577 | publication date | 1997-08-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Low medial prefrontal dopaminergic activity in autistic children | |
| P478 | volume | 350 |
| Q74296996 | 6-fluoroDOPA metabolism in rat striatum: time course of extracellular metabolites |
| Q47575039 | A candidate circuit approach to investigating autism |
| Q90540438 | A potential mechanistic role for neuroinflammation in reward processing impairments in autism spectrum disorder |
| Q34293012 | A review of executive function deficits and pharmacological management in children and adolescents. |
| Q22241891 | Antipsychotics in the treatment of autism |
| Q38122151 | Aripiprazole: a review of its use in the treatment of irritability associated with autistic disorder patients aged 6-17. |
| Q30607088 | Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy |
| Q43735958 | Bilateral medial prefrontal and temporal neocortical hypometabolism in children with epilepsy and aggression |
| Q56972087 | Borna Disease Virus |
| Q56972248 | Borna Disease Virus |
| Q34306726 | Bornavirus tropism and targeted pathogenesis: virus-host interactions in a neurodevelopmental model |
| Q37372557 | Cerebellar modulation of frontal cortex dopamine efflux in mice: relevance to autism and schizophrenia |
| Q37372356 | Connecting the dots of the cerebro-cerebellar role in cognitive function: neuronal pathways for cerebellar modulation of dopamine release in the prefrontal cortex. |
| Q59360927 | Corticosterone Signaling and a Lateral Habenula-Ventral Tegmental Area Circuit Modulate Compulsive Self-Injurious Behavior in a Rat Model |
| Q36342328 | DRD2 and PPP1R1B (DARPP-32) polymorphisms independently confer increased risk for autism spectrum disorders and additively predict affected status in male-only affected sib-pair families |
| Q36936970 | Diffusion tensor imaging of frontal lobe in autism spectrum disorder |
| Q30458917 | Effect of maternal lipopolysaccharide administration on the development of dopaminergic receptors and transporter in the rat offspring |
| Q34073325 | Emerging drugs for the treatment of symptoms associated with autism spectrum disorders |
| Q30471048 | Epac2-mediated dendritic spine remodeling: implications for disease |
| Q37706525 | Epidemiology and management of insomnia in children with autistic spectrum disorders |
| Q48893010 | Functional magnetic resonance imaging in children with Asperger's syndrome |
| Q30621009 | Functional neuroimaging in child psychiatry |
| Q30612143 | Functional neuroimaging of autistic disorders |
| Q33767197 | Glutamate dysfunction associated with developmental cerebellar damage: relevance to autism spectrum disorders |
| Q89963837 | IRSp53 Deletion in Glutamatergic and GABAergic Neurons and in Male and Female Mice Leads to Distinct Electrophysiological and Behavioral Phenotypes |
| Q36025654 | Individual differences in vulnerability for self-injurious behavior: studies using an animal model |
| Q36833588 | Is autism a disease of the cerebellum? An integration of clinical and pre-clinical research. |
| Q40493223 | Low Retinal Dehydrogenase 1 (RALDH1) Level in Prepubertal Boys with Autism Spectrum Disorder: A Possible Link to Dopamine Dysfunction? |
| Q38769865 | Mass spectrometric evaluation of neurotransmitter levels in IMR 32 cell line in response to Ayurvedic medicines |
| Q30623213 | Medication treatment in subjects with autistic spectrum disorders |
| Q59791335 | Molecular Pathology and Pharmacological Treatment of Autism Spectrum Disorder-Like Phenotypes Using Rodent Models |
| Q37022940 | Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis |
| Q24602037 | Monoamine oxidase A and A/B knockout mice display autistic-like features |
| Q90050125 | Neural Processing of Dynamic Animated Social Interactions in Young Children With Autism Spectrum Disorder: A High-Density Electroencephalography Study |
| Q22248039 | Neurobiological Correlates of Autism: A Review of Recent Research |
| Q91640241 | No Association between the rs1799836 Polymorphism of the Monoamine Oxidase B Gene and the Risk of Autism Spectrum Disorders in the Kazakhstani Population |
| Q50309956 | Pathophysiology of autism: current opinions |
| Q38450750 | Pten haploinsufficient mice show broad brain overgrowth but selective impairments in autism-relevant behavioral tests |
| Q37661363 | Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala |
| Q37372686 | Reorganization of circuits underlying cerebellar modulation of prefrontal cortical dopamine in mouse models of autism spectrum disorder |
| Q59292055 | Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings |
| Q38292201 | SPECT findings in autism spectrum disorders and medically refractory seizures |
| Q39601079 | Salivary cortisol and behavioral response to social evaluative threat in adolescents with autism spectrum disorder |
| Q36217714 | Social 'wanting' dysfunction in autism: neurobiological underpinnings and treatment implications |
| Q35755900 | Social Behavioral Deficits Coincide with the Onset of Seizure Susceptibility in Mice Lacking Serotonin Receptor 2c. |
| Q35901185 | Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer |
| Q46029915 | Striatal D₂ receptor binding in 22q11 deletion syndrome: an [¹²³I]IBZM SPECT study. |
| Q64108070 | The Gut-Immune-Brain Axis in Autism Spectrum Disorders; A Focus on Amino Acids |
| Q90396141 | The Neurochemistry of Autism |
| Q22242827 | The dopamine hypothesis of schizophrenia: version III--the final common pathway |
| Q28388719 | The dynamics of autism spectrum disorders: how neurotoxic compounds and neurotransmitters interact |
| Q61853386 | The role of candidate genes in unraveling the genetics of autism |
| Q34183868 | The role of the fusiform face area in social cognition: implications for the pathobiology of autism |
Search more.